IGF2 and cancer: Upregulated genes in mEPCs, including IGF2, GPC3, S100A4, STMN1, and MDK, were semi-automatically assigned to the traditional cancer hallmark framework (Supplementary Table S4)15, including proliferative signaling, invasion/metastasis, genomic instability, immune response, and stem cell-like program.